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An Institution Wide Interdisciplinary Protocol for 
Improving the Recognition and Treatment of 
Sepsis in Patients Presenting to the Emergency 
Department 
Glenn Oettinger, PharmD, BCPS 
Emergency Medicine Pharmacy Specialist 
Rationale for Development of the  
Severe Sepsis Protocol 
•TJUH observed to expected mortality in sepsis was found to 
be higher in comparison to UHC 
– University Health Consortium expected mortality from sepsis 21% 
– TJUH observed mortality from sepsis 34% 
– Observed/expected ratio 1.59 
– More patients died from sepsis than stroke and CHF combined 
• Implementation of a severe sepsis protocol reduces 
mortality* 
 
*The Surviving Sepsis Campaign. Crit Care Med 2010(38):367. 
Objectives of the Severe Sepsis Initiative 
1. Creation of a permanent interdisciplinary committee  
2. Create a protocol to streamline the recognition and treatment of 
sepsis 
3. Develop and conduct education for all clinical staff 
4. Monitor effectiveness 
5. Continuous quality improvement 
 
 
Creation of a permanent interdisciplinary 
committee 
• Meets monthly 
• Physicians, Nurses, Pharmacists, Administrators, Support Staff 
• ED, MICU, ID, IS 
 
• Concerns to anticipate based on our experience 
• Turnover of members 
• Waning interest 
• Delegation of work 
 
• Utilization of residents (Pharmacy, Medicine) 
 
 
 
Create a protocol to streamline the 
recognition and treatment of sepsis 
 • Consensus difficult to obtain at first 
•Objectivity vs Subjectivity 
• Scope of practice 
– Nursing FLO (first line orders) 
 
 
Steps to Early Recognition and 
Management of Sepsis in ED 
• First step: SIRS alert and clinical evaluation 
• Second step: Sepsis Workup first line order set 
• Third step: Initiate Severe Sepsis Order Set/Pathway 
and rapid triage to ICU 
Severe Sepsis Order Set/Pathway 
•Assess airway 
•Insert/maintain 2 peripheral IV lines (18 gauge or larger) or 
place TLC for central IV access. 
•Obtain LACTATE, blood cultures x 2, baseline CBC with diff, 
Chem 7, Accucheck, VBG, U/A with culture, PT/PTT, and CXR 
(if not done).   
– Obtain further labs as indicated e.g. other cultures, cortisol level, 
LFTs, urine pregnancy. 
Develop and conduct education for all 
clinical staff 
 • Power Point Presentation 
– Delivered to all staff with any potential role caring for ED 
patients (attendings, residents, NPs, nurses, pharmacists) 
– Comprehensive  
• No assumptions made on what they already know about 
the sepsis continuum  
• Pre- and post test to measure education success 
• Pocket Cards 
– Side one: Sepsis work-up, diagnosis 
– Side two: Treatment, special circumstances 
• Additional resources: Compatibility chart for sepsis meds 
Monitor effectiveness 
 
• Adherence to components of Sepsis Protocol 
– Case identification via ED charting diagnosis of sepsis 
– Review and chart abstracting by ONE clinical nurse specialist  
– Assessed for quality measures and documentation 
• Brought to Sepsis committee for further review and final consensus 
decision  
• Meets Severe Sepsis Criteria:?  Yes/No 
• Adherent to Severe Sepsis Management Protocol?  Yes/No 
• Reduction of in-hospital mortality due to sepsis 
– Measured over time 
 
Continuous quality improvement 
 
• Fall-outs/cases NOT adherent to management protocol  
– Referred to ED Performance Improvement Committee for 
more in-depth peer review 
– Follow-up with  
• Clinical staff (ED, Pulm/Crit Care, Pharmacy) 
• Sepsis Committee 
• Changes in protocol 
– Guideline updates 
– Practical changes 
Outcomes 
• Inpatient mortality: All patients with diagnosis related group 
(DRG) of sepsis 
– 6 month time period (Mar-Sep), 2011 vs. 2012  
– 24.9% (n=170) vs. 16.23% (n-289) (p=0.049) 
• Inpatient mortality index from Sepsis: Observed deaths 
TJUH/Expected deaths UHC 
–  1.31 vs. 0.94 (p=0.318) 
Subgroup Analysis: Process Measures
  
Measures associated with optimal Sepsis care pre- vs. post- 
protocol implementation (studied over 2 months) 
1. Blood cultures drawn before antibiotic administration: 
– 57.9% vs. 96.9% (p=0.001) 
2. Rate of early antibiotic administration (within 3 hours) 
– 57.9% vs. 84.4% (p=0.005) 
3. Adequate fluid resuscitation in hypotensive patients 
– 62.5% vs. 93.8% (p=0.012) 
4. Initiation of vasopressors for persistent hypotension 
– 23.1% vs. 77.8% (p=0.004) 
Results 
• Early recognition and aggressive goal directed treatment of 
sepsis has been shown to improve clinical outcomes 
• Implementation of a targeted educational program and a 
protocolized system has increased adherence to key 
interventions and reduced mortality in the study group 
 
Key Elements to Our Success 
1. Interdisciplinary and interdepartmental involvement of all the 
stakeholders in sepsis care  
• Key to identification of specific barriers to optimal care 
2. Targeted educational programs emphasizing the importance of 
early recognition of sepsis and the value of protocolized care 
3. Collaboration with IS to find innovative uses for our current 
EMRs, including the development of automated sepsis alerts to 
facilitate early recognition of patients at risk as well as bundled 
order sets 
4. A process of continuous review of performance with regular 
feedback to practitioners 
Thank You! 
 
Questions? 
SIRS/Sepsis: ACCP/SCCM Definitions 
• Infection: inflammatory response to microorganisms, or invasion of 
normally sterile body tissues 
• Systemic Inflammatory Response Syndrome (SIRS): systemic response 
to a variety of insults (burns, trauma, pancreatitis, infection) 
• Sepsis is SIRS in the setting of suspected or proven infection 
 
 
SIRS/Sepsis: Definitions 
SIRS:  presence of  2 or more of the following criteria 
– Fever (core temperature > 38.3 C or 101.0 F) or hypothermia (core 
temperature < 36 C or 96.8 F) 
– Heart rate > 90 beats/min 
– Respiratory rate > 20 breaths/min or PaCO2 < 32 or need for 
mechanical ventilation for an acute respiratory process 
– WBC > 12,000/mm3, < 4,000/mm3, or bands > 10% 
Sepsis:  patient has SIRS and a suspected or confirmed 
infection. 
Potential Clinical Clues for Suspected 
Infection 
History/symptoms 
• Fever, chills, lethargy, or malaise 
• Productive cough 
• Headache 
• Sore throat 
• Diarrhea, abdominal pain 
• Dysuria, cloudy urine 
• Sick contacts 
• Recent surgery/instrumentation 
• Recent chemotherapy 
Signs 
• Disorientation 
• Tachypnea 
• Tachycardia 
• Hypoxia 
• Hyper/hypo-thermia 
• Decreased urine output 
• Hypotension 
Continuum from Sepsis to Septic Shock 
• Sepsis 
– 2 SIRS criteria plus suspected or documented infection 
• Severe sepsis 
– Sepsis plus at least one organ dysfunction (see next slide) 
• Septic shock 
– Sepsis plus persistent hypotension despite fluid resuscitation, or 
– Perfusion abnormalities 
“Golden Hours of Sepsis” 
•Early recognition and intervention of patients with severe 
sepsis leads to improved outcomes 
•Similar concept to: 
– Acute coronary syndrome 
– Stroke 
– Trauma 
History of multi-drug resistant gram negative infection/colonization within past 90 days 
OR 
Prior broad spectrum IV antibiotics within a hospital or long term care facility for > 72 hrs within previous 14 days 
Beta Lactam Allergy 
 
Beta Lactam Allergy 
 
NO YES 
Aztreonam 
+ 
Vancomycin 
+ 
Tobramycin 
+ or - 
Metronidazole 
add metronidazole only if 
intra-abdominal infection 
suspected 
 
Meropenem 
+ 
Vancomycin 
+ 
Amikacin 
 
Consider previous susceptibilities 
and/or ID consultation 
Aztreonam 
+ 
Vancomycin 
+ 
Amikacin 
+ 
Tigecycline 
 
Consider previous susceptibilities and/or ID 
consultation 
 
Pip/Tazo 
+ 
Vancomycin 
+ 
Tobramycin 
 
SUBSTITUTE 
Ceftriaxone  
for pip/tazo in suspected meningitis 
 
 
If suspected intra-abdominal catastrophe (i.e. perforation) suspected, add micafungin 
If community acquired or health-care associated pneumonia is suspected, add azithromycin 
YES NO 
Start antibiotics  
within 1 hour  
of recognizing suspected 
severe sepsis 
Start antibiotics  
within 1 hour  
of recognizing suspected 
severe sepsis 
NO YES 
Antibiotic Compatibilities 1,2 
Amik Anid Azith Aztre Ceftri Dopa Epi Line Mero Met Mica Moxi Norepi P/T Tig Tobra Vanco 
Amikacin (Amik) - C - C - - - C - C - - - C C - C 
Anidulafungin (Anid) C - - - - C C C C C - - C C - C C 
Azithromycin (Azith) - - - - - - - - - - - - - - C - - 
Aztreonam (Aztre) C - - - - C C C - - - - - C C C C 
Ceftriaxone (Ceftri) - - - - - - - - - - - - - - - - - 
Dopamine (Dopa) - C - C - - C C - C C - C C C - C 
Epinephrine (Epi) - C - C - C - - - - - - - - C - C 
Linezolid (Line) C C - C - C - - C C - - - C C C C 
Meropenem (Mero) - C - - - - - C - - - - C - - - C 
Metronidazole (Met) C C - - - C - C - - - - - C - - - 
Micafungin (Mica) - - - - - C - - - - - - C - - - - 
Moxifloxacin (Moxi) - - - - - - - - - - - - - - - - - 
Norepinephrine (Norepi) - C - - - C - - C - C - - - C - - 
Piperacillin/ Tazobactam 
(P/T) C C - C - C - C - C - - - - C - - 
Tigecycline (Tig) C - C C - C C C - - - - C C - C C 
Tobramycin (Tobra) - C - C - - - C - - - - - - C - - 
Vancomycin (Vanco) C C - C - C C C C - - - - - C - - 
1. King Guide to Parenteral Admixture 
2. Handbook on Injectable Drugs (Trissel) 
Early Antibiotics Improves Survival in 
Septic Shock 
Antibiotic Management 
Important Things to Remember 
1. Check antibiotic compatibilities to see if antibiotics can be 
administered concurrently 
2. If antibiotics can not be administered together due to 
incompatibility (e.g. piperacillin/tazobactam and tobramycin), 
use second peripheral IV line (or different lumens of TLC) to 
avoid delay 
3. If only one IV line available, give gram negative agent first 
(piperacillin/tazobactam, aztreonam, or meropenem) unless 
specified (e.g. suspect gram positive line infection) 
 
Acute Organ Dysfunction in Severe Sepsis 
Tachycardia 
Hypotension 
Vasodilatation 
 Contractility 
Jaundice 
 Enzymes 
 Albumin 
 PT 
Altered 
Consciousness 
Confusion 
Psychosis 
Tachypnea 
PaO2 <70 mm Hg 
SaO2 <90% 
PaO2/FiO2 300  
Oliguria 
Anuria 
 Creatinine 
 Platelets 
 PT/APTT 
 Protein C 
 D-dimer 
Neuropathy 
Myopathy 
Increased Mortality Along a Continuum 
Rangel-Frausto, et al. JAMA 1995;273:117-23. 
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Severe Sepsis Criteria 
Patient meets sepsis definition and has at least 1 sign of organ 
dysfunction*: 
– SBP < 90 mmHg, MAP < 65 mmHg for at least one hour despite 
adequate fluid resuscitation (30 ml/kg saline) or use of vasopressors  
– Lactate > 4 mmol/L 
– Urine output < 0.5 ml/kg/hr after adequate fluid resuscitation or rise in 
creatinine > 0.5 mg/dL over baseline 
– PaO2/FiO2 ratio < 300 or requiring > 4 liters oxygen via nasal 
cannula to maintain SpO2 >  90% 
– Platelets < 100,000/mm3, INR > 1.5, PTT > 60s 
 
*Organ dysfunction must be new onset 
 
Severe Sepsis Order Set/Pathway 
(cont’d) 
•Begin broad spectrum IV antibiotics within 1 hour of 
RECOGNITION of severe sepsis* (see Figure) 
•Administer 0.9% sodium chloride x 2 liter IV fluid bolus (or 
30cc/kg) 
•Place foley catheter to monitor urine output 
 
Severe Sepsis Order Set (continued) 
•If MAP < 65 or SBP < 90 after initial bolus, place central 
venous line (preferably SC or IJ) and initiate vasopressors 
 
•Continue IV fluids as per physician discretion 
 
•Document vital signs (HR, BP including MAP, RR, O2 sat) 
and I&Os Q1hour x 2 sets, then frequency as per physician 
discretion 
Early Recognition and Management 
of Sepsis in Inpatients 
 
• First step: SIRS alert and clinical evaluation 
• Second step: Send BC x2 and lactate 
• Third step: Initiate Severe Sepsis Order Set/Pathway 
and promptly transfer to ICU 
 
Antibiotic Management 
•Begin intravenous antibiotics within 1 hour of recognizing 
severe sepsis 
•Use broad spectrum agents active against likely 
bacterial/fungal pathogens and with good penetration into 
presumed source (see Figure on next slide) 
•Reassess antimicrobial regimen daily to optimize efficacy, 
prevent resistance, and avoid toxicity  
Hemodynamic Management 
•Administer 0.9% Sodium chloride 30 ml/kg IV bolus for 
volume resuscitation 
• If MAP < 65 or SBP < 90 after initial bolus, place central 
venous line (ideally SC or IJ) and initiate vasopressors  
•Continue IV fluids as per physician discretion 
 
Vasopressor Management 
• If MAP < 65 or SBP < 90 after initial volume resuscitation, 
initiate norepinephrine at 0.1 mcg/kg/min (preferred) 
• If patient has persistent or increasing vasopressor 
requirements, initiate epinephrine or vasopressin infusion 
•All patients on vasopressors require vital signs with every 
titration and every 1 hour once blood pressure goal is achieved 
– IV site should be checked frequently if administered peripherally 
Importance of Documentation 
• Document in a manner that is accurate and accessible to all 
disciplines: 
– Necessary for the ongoing treatment of the patient 
– Necessary to monitor quality of care metrics 
• Blood cultures before antibiotics 
• Early, appropriate, adequate antibiotics 
• Initial fluid resuscitation 
• Use of vasopressors for hypotension despite initial fluids 
Rapid Triage to ICU 
• Patients identified as having SEVERE SEPSIS should be 
admitted/transferred to ICU promptly: 
****Process of transfer should not delay therapy **** 
• Antibiotics MUST be initiated at current location 
• Provide vasopressors, additional IV fluids, perform 
imaging, etc. as needed prior to transfer 
Continued Sepsis Management 
• Promptly de-escalate/ alter antibiotics based on culture results and other 
clinical data  
• Stop antimicrobial therapy if cause found to be noninfectious  
• Remove catheters (central lines, foley) as soon as no longer required 
• Limit duration of antibiotic therapy to 7-10 days; longer if response is 
slow or there are undrainable foci of infection or immunologic 
deficiencies   
 
